Classification of primary ciliary dyskinesia

Primary ciliary dyskinesia (PCD) is a rare hereditary disease from the group of ciliopathies with extensive locus and allelic heterogeneity (ORPHA 244, 98861; OMIM 242650, 244000). This disease is inherited by autosomal dominant or autosomal recessive type and, less often, by X-linked type (OMIM 300424). Retinitis pigmentosa develops in the X-linked PCD variant. The overall minimum global prevalence of PCD according to European data is 1 : 7554. There is no generally accepted classification of PCD in the international classification of diseases (ICD), 10th revision. PCD is not presented in ICD-10 as a separate medical entity, and the code Q32.4 – Other congenital bronchial anomalies – is used for coding. In the new edition of ICD-11, the code LA75.Y is highlighted – Other specified structural abnormalities of the lungs.

Primary ciliary dyskinesia. However, there is no generally accepted classification of PCD. The aim of the study was to develop a classification of primary ciliary dyskinesias to improve the efficiency of medical care for patients during follow-up.

Methods. European and Russian clinical recommendations, as well as ICD 10th and 11th revision, Classification of Respiratory Insufficiency (2020), Order of 27.08.19 No.585n “On classifications and criteria used in the implementation of medical and social expert assessment of citizens by federal state institutions of medical and social expert assessment” (as amended on 06.10.21) were used to create the classification.

Results. The classification of PCD was created and can be recommended for use in clinical practice. The classification was based on the presence or absence of the Sievert – Kartagener syndrome (complete, not complete), as well as clinical and instrumental characterization of bronchopulmonary changes based on the presence of chronic obstructive bronchitis, bronchiectasis (specifying the type and localization), pneumofibrosis with the process activity (exacerbation, remission), and the degree of respiratory failure. It is recommended to take into account extrapulmonary manifestations of PCD, such as rhinosinusitis, media otitis, congenital heart defect, and complications. It is recommended to use the PICADAR (PrImary CiliAry DyskinesiA Rule) score and to include the results of video microscopy, DNA diagnosis, and microbiological examination in the diagnosis.

Conclusion. The application of the proposed classification can be useful in the dynamic observation of the patient, therapy and in the conduct of medical and social expert assessment.

1. Hannah W.B., Seifert B.A., Truty R. et al. The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis. Lancet Respir. Med. 2022; 10 (5): 459–468. DOI: 10.1016/S2213-2600(21)00453-7.

2. [Clinical guidelines: Primary ciliary dyskinesia]. Available at: https://www.pediatr-russia.ru/information/events/Проект%20ПЦД%20-%202021_на%20сайт.pdf (in Russian).

3. Kondratyeva E.I., Avdeev S.N., Mizernitskiy Yu.L. et al. [Primary ciliary dyskinesia: review of the draft clinical guidelines]. Pul'monologiya. 2022; 32 (4): 517–538. DOI: 10.18093/0869-0189-2022-32-4-517-538 (in Russian).

4. Nikolaeva E.D., Ovsyannikov D.Yu., Strel’nikova V.A. et al. [Characteristics of patients with primary ciliary dyskinesia]. Pul'monologiya. 2023; 33 (2): 198–209. DOI: 10.18093/0869-0189-2023-33-2-198-209 (in Russian).

5. Boaretto F., Snijders D., Salvoro C. et al. Diagnosis of primary ciliary dyskinesia by a targeted next-generation sequencing panel: molecular and clinical findings in Italian patients. J. Mol. Diagn. 2016; 18 (6): 912–922. DOI: 10.1016/j.jmoldx.2016.07.002.

6. Moore A., Escudier E., Roger G. et al. RPGR is mutated in patients with a complex X linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa. J. Med. Genet. 2006; 43 (4): 326–333. DOI: 10.1136/jmg.2005.034868.

7. Paff T., Loges N.T., Aprea I. et al. Mutations in PIH1D3 cause X-linked primary ciliary dyskinesia with outer and inner dynein arm defects. Am. J. Hum. Genet. 2017; 100 (1): 160–168. DOI: 10.1016/j.ajhg.2016.11.019.

8. Kennedy M.P., Omran H., Leigh M.W. et al. Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation. 2007; 115 (22): 2814–2821. DOI: 10.1161/CIRCULATIONAHA.106.649038.

9. Deng H., Xia H., Deng S. Genetic basis of human left-right asymmetry disorders. Expert Rev. Mol. Med. 2015; 16: e19. DOI: 10.1017/erm.2014.22.

10. Lucas J.S.A., Walker W.T., Kuehni C.E., Lazor R. Primary ciliary dyskinesia. In: Courdier J.F., ed. Orphan lung diseases. Lausanne: European Respiratory Society; 2011. Ch. 12: 201–217. DOI: 10.1183/1025448x.10008310.

11. Ullmann N., Porcaro F., Petreschi F. et al. Noncystic fibrosis bronchiectasis in children and adolescents: Follow-up over a decade. Pediatr. Pulmonol. 2021; 56 (9): 3026–3034. DOI: 10.1002/ppul.25553.

12. Knowles M.R., Zariwala M., Leigh M. Primary ciliary dyskinesia. Clin. Chest Med. 2016; 37 (3): 449–461. DOI: 10.1016/j.ccm.2016.04.008.

13. Shoemark A., Harman K. Primary ciliary dyskinesia. Semin. Respir. Crit. Care Med. 2021; 42 (4): 537–548. DOI: 10.1055/s-0041-1730919.

14. Novak A.A., Mizernitskiy Yu.L. [Primary ciliary dyskinesia: state of the problem and prospects]. Meditsinskiy sovet. 2021; (1): 276–285. DOI: 10.21518/2079-701X-2021-1-276-285 (in Russian).

15. Lucas J.S., Barbato A., Collins S.A. et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur. Respir. J. 2017; 49 (1): 1601090. DOI: 10.1183/13993003.01090-2016.

16. O’Callaghan C., Chetcuti P., Moya E. High prevalence of primary ciliary dyskinesia in a British Asian population. Arch. Dis. Child. 2010; 95 (1): 51–52. DOI: 10.1136/adc.2009.158493.

17. Chuchalin A.G. [Pulmonology]. Moscow: GEOTAR-Media; 2020 (in Russian).

18. Lucas J.S., Gahleitner F., Amorim A. et al. Pulmonary exacerbations in patients with primary ciliary dyskinesia: an expert consensus definition for use in clinical trials. ERJ Open Res. 2019; 5 (1): 00147-2018. DOI: 10.1183/23120541.00147-2018.

19. Behan L., Dimitrov B.D., Kuehni C.E. et al. PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia. Eur. Respir. J. 2016; 47 (4): 1103–1112. DOI: 10.1183/13993003.01551-2015.

20. Martinů V., Bořek-Dohalská L., Varényiová Ž. et al. Evaluation of a clinical index as a predictive tool for primary ciliary dyskinesia. Diagnostics (Basel). 2021; 11 (6): 1088. DOI: 10.3390/diagnostics11061088.

21. Ministry of Health of the Russian Federation. [Clinical recommendations: Cystic fibrosis]. 2021. Available at: https://cr.minzdrav.gov.ru/schema/372_2?ysclid=lnlpxyte1u764090025 (in Russian).

22. Lee T.W.R., Brownlee K.G., Conway S.P. et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis. J. Cyst. Fibros. 2003; 2 (1): 29–34. DOI: 10.1016/S1569-1993(02)00141-8.

23. Fretzayas A., Moustaki M. Clinical spectrum of primary ciliary dyskinesia in childhood. World J. Clin. Pediatr. 2016; 5 (1): 57–62. DOI: 10.5409/wjcp.v5.i1.57.

24. Vallet C., Escudier E., Roudot-Thoraval F. et al. Primary ciliary dyskinesia presentation in 60 children according to ciliary ultrastructure. Eur. J. Pediatr. 2013; 172 (8): 1053–1060. DOI: 10.1007/s00431-013-1996-5.

25. Demchenko A.G., Smirnikhina S.A. [Ciliated cell cultures for diagnosis of primary ciliary dyskinesia]. Pul'monologiya. 2023; 33 (2): 210–215. DOI: 10.18093/0869-0189-2023-33-2-210-215 (in Russian).

26. Olbrich H., Häffner K., Kispert A. et al. Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat. Genet. 2002; 30 (2): 144–144. DOI: 10.1038/ng817.

27. Werner C., Onnebrink J.G., Omran H. Diagnosis and management of primary ciliary dyskinesia. Cilia. 2015; 4 (1): 2. DOI: 10.1186/s13630-014-0011-8.

28. Shoemark A., Pinto A.L., Patel M.P. et al. PCD Detect: enhancing ciliary features through image averaging and classification. Am. J. Physiol. Lung Cell. Mol. Physiol. 2020; 319 (6): L1048–1060. DOI: 10.1152/ajplung.00264.2020.

29. Bukowy-Bieryllo Z., Rabiasz A., Dabrowski M. et al. Truncating mutations in exons 20 and 21 of OFD1 can cause primary ciliary dyskinesia without associated syndromic symptoms. J. Med. Genet. 2019; 56 (11): 769–777. DOI: 10.1136/jmedgenet-2018-105918.

30. Leigh M.W., Ferkol T.W., Davis S.D. et al. Clinical features and associated likelihood of primary ciliary dyskinesia in children and adolescents. Ann. Am. Thorac. Soc. 2016; 13 (8): 1305–1313. DOI: 10.1513/AnnalsATS.201511-748OC.